OM:SOBIBiotechs
SOBI (OM:SOBI) Margin Plunge and SEK7.1B Loss Challenge Rebound Narrative
Swedish Orphan Biovitrum (OM:SOBI) reported net profit margins of just 0.05% for the twelve months to September 30, 2025, with a hefty non-recurring loss of SEK7.1 billion weighing on results. This is down sharply from last year’s margin of 13.8%. Over the past five years, earnings have slipped by an average of 0.6% per year, and profits turned negative over the most recent period. Despite this, forward-looking estimates are optimistic, with annual earnings growth projected at 43.3% and...